ABBVIE INC (ABBV)

US00287Y1091 - Common Stock

167.8  -1.74 (-1.03%)

After market: 167.8 0 (0%)

Buy % Consensus

77

ChartMill assigns a Buy % Consensus number of 77% to ABBV. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 188.18. This target is 12.15% above the current price.
ABBV was analyzed by 35 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about ABBV.
In the previous month the buy percentage consensus was at a similar level.
ABBV was analyzed by 35 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 167.80162.61193.17188.18217.35 - -3.09% 15.12% 12.15% 29.53%
Up and Down Grades
Date Firm Action Rating
2024-03-27 Barclays Maintains Overweight -> Overweight
2024-03-22 Guggenheim Maintains Buy -> Buy
2024-02-06 Raymond James Maintains Outperform
2024-02-06 Truist Securities Maintains Buy -> Buy
2024-02-05 BMO Capital Maintains Outperform -> Outperform
2024-02-05 Barclays Maintains Overweight -> Overweight
2024-02-05 Raymond James Maintains Outperform -> Outperform
2024-01-29 William Blair Upgrade Market Perform -> Outperform
2024-01-23 Barclays Maintains Overweight -> Overweight
2023-12-18 HSBC Downgrade Buy -> Hold
2023-12-11 Goldman Sachs Upgrade Neutral -> Buy
2023-12-01 Raymond James Maintains Outperform -> Outperform
2023-11-09 Deutsche Bank Initiate Hold
2023-10-30 Barclays Upgrade Equal-Weight -> Overweight
2023-10-30 Morgan Stanley Maintains Overweight -> Overweight
2023-10-11 Morgan Stanley Maintains Overweight -> Overweight
2023-09-29 Raymond James Initiate Outperform
2023-07-28 Piper Sandler Maintains Overweight -> Overweight
2023-07-25 William Blair Initiate Market Perform
2023-07-14 HSBC Initiate Buy
2023-07-11 Morgan Stanley Reiterate Overweight -> Overweight
2023-04-28 Guggenheim Maintains Buy
2023-04-28 Wells Fargo Maintains Overweight
2023-04-28 Morgan Stanley Maintains Overweight
2023-04-10 Morgan Stanley Maintains Overweight
2023-04-05 Argus Research Downgrade Buy -> Hold
2023-03-01 Guggenheim Initiate Buy
2023-02-22 Wolfe Research Downgrade Outperform -> Peer Perform
2023-02-10 Atlantic Equities Maintains Neutral
2023-02-10 SVB Leerink Upgrade Underperform -> Market Perform